Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...

A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...

This review synthesizes progress in pathway optimization, regulatory rewiring, and microbial cell factory design that has ...

Speaking during her recent trip to Israel, which centered on the HealthTech AI Summit 2025, chaired by Prof. Ran Balicer, ...

There is a comforting assumption in football that greatness should be transferable. If a player could see angles no one else ...

A new report by HEPI and Taylor & Francis explores the potential of AI to advance translational research and accelerate the ...

Time-restricted eating has gained popularity in recent years, but a recent study suggests that intermittent fasting — while effective for weight loss — might not live up to the hype in terms of wider ...

Experts say the next major rally may come only when long-term holders are exhausted, and true institutional capital enters ...

Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...

Goertek, a key player in the extended reality (XR) ecosystem, marked its presence at this year's CES in Las Vegas, which opened on January 6, with the launch of its expansive "XR New Year Package." ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Ottimo Pharma Limited ("Ottimo"), an innovative, ...